Counterpath Corp
CPAH
CPAH was delisted on the 26th of February, 2021.
9 hedge funds and large institutions have $586K invested in Counterpath Corp in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
50% more funds holding
Funds holding: 6 → 9 (+3)
12% less capital invested
Capital invested by funds: $665K → $586K (-$79K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$25.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.96K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$418 |
| 4 |
ACM
Aviance Capital Management
Sarasota,
Florida
|
+$13 |
Top Sellers
CPAH Hedge Fund Activity: Q2 2017 in Review
9 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Counterpath Corp (CPAH) for Q2 2017, worth a combined $586K — down 12% from $665K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CPAH positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $25.7K.
- 9 institutional investors held Counterpath Corp (CPAH) as of Q2 2017, up from 6 in Q1 2017.
- Funds reported $586K of Counterpath Corp stock for Q2 2017, down 12% quarter-over-quarter.
- 3 funds opened new Counterpath Corp positions in Q2 2017 and 0 closed out, a net change of +3 holders.
- The largest Counterpath Corp buyer in Q2 2017 was Citadel Advisors, an estimated $25.7K added.
Based on aggregated 13F filings for Q2 2017.